{"id":3630,"date":"2021-01-14T14:23:01","date_gmt":"2021-01-14T11:23:01","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=3630"},"modified":"2021-01-16T17:24:45","modified_gmt":"2021-01-16T14:24:45","slug":"klimikten-coronavaca-karsi-tereddudu-engellemek-icin-seffaflik-vurgusu","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/klimikten-coronavaca-karsi-tereddudu-engellemek-icin-seffaflik-vurgusu\/","title":{"rendered":"KL\u0130M\u0130K&#8217;ten CoronaVac&#8217;a Kar\u015f\u0131 Teredd\u00fcd\u00fc Engellemek \u0130\u00e7in \u015eeffafl\u0131k Vurgusu"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-56413 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2016\/11\/T24_haber_sitesi_logo.jpg\" alt=\"\" width=\"60\" height=\"60\" \/><strong>T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Derne\u011fi (KL\u0130M\u0130K), Pfizer-Biontech, Moderna, Oxford-AstraZeneca ve T\u00fcrkiye&#8217;nin de sat\u0131n ald\u0131\u011f\u0131 CoronaVac a\u015f\u0131s\u0131 hakk\u0131nda yapt\u0131klar\u0131 a\u00e7\u0131klamada, d\u00f6rt a\u015f\u0131n\u0131n da hastal\u0131\u011f\u0131 \u00f6nleme konusundaki etkilerinin farkl\u0131 olmakla birlikte a\u011f\u0131r hastal\u0131k ve \u00f6l\u00fcmleri \u00f6nleme konusunda etkilerinin y\u00fczde 100&#8217;e yak\u0131n oldu\u011funa vurgu yapt\u0131.<\/strong><\/p>\n<p>KL\u0130M\u0130K&#8217;ten yap\u0131lan a\u00e7\u0131klamada, &#8220;Farkl\u0131 ya\u015f ve risk gruplar\u0131nda etkililik ve yan etki a\u00e7\u0131s\u0131ndan birbirlerine \u00fcst\u00fcnl\u00fckleri olabildi\u011fi, bug\u00fcne kadarki veriler \u0131\u015f\u0131\u011f\u0131nda hi\u00e7birinin ciddi yan etki olu\u015fturmad\u0131\u011f\u0131 s\u00f6ylenebilir&#8221; denildi. A\u00e7\u0131klamada, T\u00fcrkiye&#8217;de uygulanmaya ba\u015flanan CoronaVac a\u015f\u0131s\u0131na kar\u015f\u0131 teredd\u00fctlerin engellenmesi i\u00e7in T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu taraf\u0131ndan kamuoyunun \u015feffaf bir \u015fekilde bilgilendirilmesi gerekti\u011fi vurgusu yap\u0131ld\u0131.<\/p>\n<p>KL\u0130M\u0130K, koronavirusa kar\u015f\u0131 geli\u015ftiren ve pek \u00e7ok \u00fclkede acil kullan\u0131m onay\u0131 olan Pfizer-Biontech, Moderna, Oxford-AstraZeneca ve CoronaVac hakk\u0131nda a\u00e7\u0131klama yapt\u0131.<\/p>\n<p><a href=\"https:\/\/t24.com.tr\/haber\/klimik-ten-corona-vac-a-karsi-tereddudu-engellemek-icin-seffaflik-vurgusu-4-asinin-da-agir-hastalik-ve-olumleri-onleme-etkileri-yuzde-100-e-yakin,926509\"><strong>Haberin Devam\u0131 \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>T\u00fcrk Klinik Mikrobiyoloji ve \u0130nfeksiyon Hastal\u0131klar\u0131 Derne\u011fi (KL\u0130M\u0130K), Pfizer-Biontech, Moderna, Oxford-AstraZeneca ve T\u00fcrkiye&#8217;nin de sat\u0131n ald\u0131\u011f\u0131 CoronaVac a\u015f\u0131s\u0131 hakk\u0131nda yapt\u0131klar\u0131 a\u00e7\u0131klamada, d\u00f6rt a\u015f\u0131n\u0131n da hastal\u0131\u011f\u0131 \u00f6nleme konusundaki etkilerinin farkl\u0131 olmakla birlikte a\u011f\u0131r hastal\u0131k ve \u00f6l\u00fcmleri \u00f6nleme konusunda etkilerinin y\u00fczde 100&#8217;e yak\u0131n oldu\u011funa vurgu yapt\u0131. KL\u0130M\u0130K&#8217;ten yap\u0131lan a\u00e7\u0131klamada, &#8220;Farkl\u0131 ya\u015f ve risk gruplar\u0131nda etkililik ve yan etki a\u00e7\u0131s\u0131ndan birbirlerine \u00fcst\u00fcnl\u00fckleri olabildi\u011fi, bug\u00fcne kadarki veriler \u0131\u015f\u0131\u011f\u0131nda hi\u00e7birinin ciddi yan etki olu\u015fturmad\u0131\u011f\u0131 s\u00f6ylenebilir&#8221; denildi. A\u00e7\u0131klamada, T\u00fcrkiye&#8217;de uygulanmaya ba\u015flanan CoronaVac a\u015f\u0131s\u0131na kar\u015f\u0131 teredd\u00fctlerin engellenmesi i\u00e7in T\u00fcrkiye \u0130la\u00e7 ve T\u0131bbi Cihaz Kurumu taraf\u0131ndan kamuoyunun \u015feffaf bir \u015fekilde bilgilendirilmesi gerekti\u011fi vurgusu yap\u0131ld\u0131. KL\u0130M\u0130K, koronavirusa kar\u015f\u0131 geli\u015ftiren [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":3631,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/3630"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=3630"}],"version-history":[{"count":1,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/3630\/revisions"}],"predecessor-version":[{"id":3632,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/3630\/revisions\/3632"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/3631"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=3630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=3630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=3630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}